Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Chronological

View all 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Archive
 

Recommendations - 2014

Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
Source: MMWR, February 7, 2014; 63(05):108–109
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
Source: MMWR, February 7, 2014; 63(5):110–112
HTML  |  PDF
 

Recommendations - 2013

CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
Source: MMWR, December 20, 2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Summary Recommendations: Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2013–14
Released: August 7, 2013
HTML  |  PDF
Updated Recommendations for Use of VariZIG -- United States, 2013
Source: MMWR, July 19, 2013; 62(28):574-6
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
Source: MMWR, May 10, 2013; 62(18):356
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
Advisory Committee on Immunization Practices (ACIP) Recommended Immunization Schedules for Persons Aged 0 Through 18 years and Adults Aged 19 Years and Older — United States, 2013
Source: MMWR Supplements, February 1, 2013; 62(01):1-21
HTML  |  PDF
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
 

Recommendations - 2012

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012; 61(40):816-9
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8
HTML  |  PDF
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
(Not an ACIP statement but an important document from CDC.)
Source: MMWR, July 6, 2012; 61(RR03):1-12
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years - United States, 2012
Source: MMWR, February 10, 2012; 61(5):1-4
HTML  |  PDF
Recommended Adult Immunization Schedule — United States, 2012
Source: MMWR, February 3, 2012; 61(4):1-7
HTML  |  PDF
 

Recommendations - 2011

Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 26, 2011; 60(33):1128-1132
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years -- United States, 2011
Source: MMWR, February 11, 2011; 60(5):1-4
HTML  |  PDF
Recommended Adult Immunization Schedule --- United States, 2011
Source: MMWR, February 4, 2011; 60(04):1-4
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 

Recommendations - 2010

Sexually Transmitted Diseases Treatment Guidelines, 2010
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110
HTML  |  PDF
 
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
 
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
 
Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Source: MMWR, August 13, 2010; 59(31):989-92
HTML  |  PDF
 
Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, August 6, 2010; 59(rr08):1-62
HTML  |  PDF
 
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, July 30, 2010; 59(RR07):1-27
HTML  |  PDF
 
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010; 59(rr06):1-36
HTML  |  PDF
 
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
 
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486
HTML  |  PDF
 
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010; 59(02):1-9
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):273
HTML  |  PDF
 
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
 
Japanese Encephalitis Vaccines
Source: MMWR, March 12, 2010; 59(01):1-27
HTML  |  PDF
 
Recommended Adult Immunization Schedule--United States, 2010
Source: MMWR, January 15, 2010; 59(01:1-4)
HTML  |  PDF
 
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--United States, 2010
Source: MMWR, January 8, 2010; 58(51&52):1-4
HTML  |  PDF
 

Recommendations - 2009

Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Source: MMWR, September 25, 2009; 58(37):1042-1043
HTML  |  PDF
 
Updated Recommendations from the Advisory Committee on Immunization Practices (ACIP) for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
Source: MMWR, September 18, 2009; 58(36):1006-1007
HTML  |  PDF
 
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
Source: MMWR September 18, 2009; 58(36):1008-1009
HTML  |  PDF
 
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics
(Not an ACIP statement, but an important new recommendation from CDC.)
Source: MMWR, September 4, 2009; 58(RR11):1-166
HTML  |  PDF
 
Use of Influenza A (H1N1) 2009 Monovalent Vaccine
Source: MMWR, August 28, 2009; 58(RR10):1-8
HTML  |  PDF
 
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination
Source: MMWR, August 7, 2009; 58(30):829-30
HTML  |  PDF
 
Prevention and Control of Seasonal Influenza with Vaccines, 2009
Source: MMWR, July 31, 2009; 58(RR08):1-52
HTML  |  PDF
 
Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12-15 Months
Source: MMWR, June 26, 2009; 58(24):673-4
HTML  |  PDF
 
Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58 (RR-2)
HTML  |  PDF
 
Recommended Adult Immunization Schedule--United States, 2009
Source: MMWR, January 9, 2009; 57(53):Q-1-Q-4
HTML  |  PDF
 
Recommended Immunization Schedules for Persons Aged 0 Through 18 Years--United States, 2009
Source: MMWR, January 2, 2009; 57(51):Q-1-Q-4
HTML  |  PDF
 

Recommendations - 2008

Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
Source: MMWR, September 19, 2008; 57(RR--8):1-20
(Not an ACIP statement, but an important new recommendation from CDC)
HTML  |  PDF
 
Prevention and Control of Influenza, Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008
Source: MMWR, August 8, 2008; 57(RR07):1-60
HTML  |  PDF
 
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 6, 2008; 57(05):1-30
HTML  |  PDF
 
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 30, 2008; 57 (04):1-47,51
Please note: If you are using the HTML version of this document, be sure to access all three HTML links to get the complete content of the document.
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
 
Human Rabies Prevention--United States, 2008: Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 23, 2008; 57(RR03):1-26,28
HTML pt 1 | HTML pt 2 |  PDF
 
ACIP: Guidance for Vaccine Recommendations in Pregnant and Breastfeeding Women
Source: Centers for Disease Control and Prevention, April 2008
HTML PDF
 
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
HTML  |  PDF
 
ACIP Recommendations: Update Regarding Administration of Combination MMRV Vaccine
Source: MMWR, March 14, 2008 / 57(10);258-260
HTML  |  PDF
 
Recommended Immunization Schedules for Persons Aged 0-18 Years--United States, 2008
Source: MMWR, January 11, 2008; 57(01):Q-1-Q-4
HTML  |  PDF
 
Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB and Comvax)
Source: MMWR, December 19, 2007; 56(Dispatch):1-2
HTML  |  PDF
 

Recommendations - 2007

Back to top
Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266
HTML  |  PDF
 
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November 23, 2007; 56(46):1217-1219
HTML  |  PDF
 
Recommended Adult Immunization Schedule: United States, Oct. 2007 - Sept. 2008
Source: MMWR, October 19, 2007; 56(41):Q1-Q4
HTML  |  PDF
 
Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084 
HTML  |  PDF
 
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
 
Prevention of Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40
 
HTML  |  PDF
 
Guidelines for Vaccinating Pregnant Women: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: Centers for Disease Control and Prevention, Updated May 2007
HTML  |  PDF
 
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
 
HTML  |  PDF
 
Recommended Immunization Schedules for Persons Aged 0-18 Years --- United States, 2007
Source: MMWR, January 5, 2007, Vol. 55(51):Q1-Q4
 
HTML  |  PDF
 

Recommendations - 2006

Back to top
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 8, 2006;55(RR-16):1-25R
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
General Recommendations on Immunization
Source: MMWR, December 1, 2006, 55(RR15):1-48
HTML  |  PDF
 
Notice to Readers: Recommendation to resume meningococcal vaccination of children aged 11-12 years
Source: MMWR, November 3, 2006, Vol. 55(43):1177
HTML  |  PDF
 
Recommended Adult Immunization Schedule: United States, Oct. 2006 - Sept. 2007
Source: MMWR, October 13, 2006, Vol. 55(40):Q1-Q4
HTML  |  PDF
 
CDC Guidelines: Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Setting
(Not an ACIP statement, but an important new recommendation from CDC)

Source: MMWR, September 22, 2006, Vol. 55(RR14):1-17
HTML  |  PDF
 
CDC Treatment Guidelines: Sexually Transmitted Diseases, 2006
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94
HTML  |  PDF
 
Prevention and Control of Influenza
Source: MMWR, July 28, 2006, Vol. 55(RR10):1-42
HTML  |  PDF
 
Control and Elimination of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630
HTML  |  PDF
 
Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease
Source: Centers for Disease Control and Prevention, June 2006
HTML  PDF
 
CDC Update: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11--12 Years
Source: MMWR, May 26, 2006 Vol. 55(20):567-568
HTML  |  PDF
 
Prevention of Hepatitis A Through Active or Passive Immunization
MMWR, May 19, 2006, Vol. 55(RR07):1-23
HTML  |  PDF
 
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7
PDF (entire issue)
 
Investigational Product (VariZIG™) for Postexposure Prophylaxis of Varicella
Source: MMWR, February 24, 2006, Vol. 55:1-2
HTML  |  PDF
 
Influenza Vaccination of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16
HTML  |  PDF
 
Recommended Childhood and Adolescent Immunization Schedule --- United States, 2006 Harmonized Childhood and Adolescent Immunization Schedule, 2006
Sources: MMWR, January 6, 2006, Vol.54(52):Q1-Q4
HTML  |  PDF
 

Recommendations - 2005

Back to top
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents.
Source: MMWR, December 23, 2005, Vol. 54(RR-16):1-39
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Postexposure Prophylaxis/Pertussis/CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
MMWR, December 9, 2005, Vol. 54(RR14):1-16
HTML  |  PDF
 
Recommended Adult Immunization Schedule: United States, Oct. 2005 - Sept. 2006
Source: MMWR, October 14, 2005, Vol. 54(40):Q1-Q4
HTML  |  PDF
 
CDC Update: Influenza Vaccine Supply and Recommendations for Prioritization During the 2005--06 Influenza Season
Source: MMWR, September 2, 2005, Vol. 54(34):850
HTML
 
ACIP Recommendations: Prevention and Control of Influenza
Source: MMWR, July 29, 2005, Vol. 54(RR-8):1-4
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
HTML  |  PDF
 

Recommendations - 2003

Back to top
CDC Guidelines: Infection Control in Dental Health-Care Settings, 2003
(not an ACIP statement but a recommendation from the National Center for Chronic Disease Prevention and Health Promotion)
Source: MMWR, December 19, 2003, Vol. 52(RR-17)
HTML  |  PDF
 
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
HTML  |  PDF
 
Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2
HTML  |  PDF
 
Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7)
HTML  |  PDF
 
Correctional Settings: Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)
Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44
PDF
 
National Association of State Public Health Veterinarians: Compendium of Animal Rabies Prevention and Control, 2003
(not an ACIP statement but an important document)
Source: MMWR, March 21, 2003, Vol. 52(RR05):1-8
HTML  |  PDF
 
Draft Recommendations for Use of Smallpox Vaccine in a Pre-Event Smallpox Vaccination Program
Currently available online only
HTML  |  PDF
 

Recommendations - 2002

Back to top
Use of Anthrax Vaccine in Response to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026
HTML  |  PDF
 
Yellow Fever Vaccine
Source: MMWR, November 8, 2002, Vol. 51/RR17
HTML  |  PDF
 
CDC Treatment Guidelines: Sexually Transmitted Diseases
(not an ACIP statement but an important document)
Source: MMWR, May 10, 2002 Vol. 51 / RR-6
(Includes information on hepatitis B and hepatitis A vaccination)
HTML  | PDF
 
General Recommendations on Immunization
Source: MMWR, February 8, 2002 Vol. 51 / RR-02
HTML  |  PDF
 

Recommendations - 2001

CDC Guidelines: Development of Community- and State-Based Immunization Registries
(not an ACIP statement but an important document)
Source: MMWR October 5, 2001 / Vol 50 / No. RR-17
HTML  |  PDF
 
CDC Guidelines: Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12
HTML  |  PDF
 
Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
(not an ACIP statement but an important update document)

Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11
HTML  |  PDF
 
Vaccinia (Smallpox) Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10
HTML  |  PDF
 
Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients
(not an ACIP statement but an important update document)
Source: MMWR, April 27, 2001 / Vol. 50 / No. RR-5
HTML  |  PDF
 

Recommendations - 2000

Back to top
Use of Anthrax Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15
HTML  |  PDF
 
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
 
Preventing Pneumococcal Disease Among Infants and Young Children
Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease
Source: MMWR June 30, 2000 / Vol. 49 / No. RR-07
HTML  |  PDF
 
Meningococcal Disease and College Students
Source: MMWR June 30, 2000 / Vol. 49 / No. RR-07
HTML  |  PDF
 
Poliomyelitis Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05
HTML  |  PDF
 
Adult Immunization Programs in Nontraditional Settings; Quality Standards and Guidance for Program Evaluation
Source: MMWR, March 24, 2000/ Vol. 49/ No. RR-01:1-13
HTML  |  PDF
 
Use of Standing Orders Programs to Increase Adult Vaccination Rates
Source: MMWR March 24, 2000 / Vol. 49 / No. RR-01
HTML  |  PDF
 

Recommendations - 1999-1991

Back to top
Prevention of Varicella Updated
Source: MMWR May 28, 1999 / Vol. 48 / No. RR-06
HTML  |  PDF
 
Combination Vaccines for Childhood Immunization
Source: MMWR May 14, 1999 / Vol. 48 / No. RR-05
HTML  |  PDF
 
Human Rabies Prevention- -United States, 1999
Source: MMWR January 8, 1999 / Vol. 48 / No. RR-1
HTML  |  PDF
 
Measles, Mumps, and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8
HTML  |  PDF
 
Immunization of Health-Care Workers
Source: MMWR December 26, 1997 / Vol. 46 / No. RR-18
HTML  |  PDF
 
Prevention of Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08
HTML  |  PDF
 
Use of Acellular Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7
HTML  |  PDF
 
Prevention of Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14
HTML  |  PDF
 
Vaccine Side Effects, Adverse Reactions, Contraindications, and Precautions
Source: MMWR September 6, 1996 / Vol. 45 / No. RR-12
HTML  |  PDF
 
Typhoid Immunization
Source: MMWR December 9, 1994/ Vol. 43/ No. RR-14
HTML  |  PDF
 
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13
HTML  |  PDF
 
Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence
Source: MMWR April 9, 1993 / Vol. 42 / No. RR-04
HTML  |  PDF
 
Inactivated Japanese Encephalitis Virus Vaccine
Source: MMWR January 8, 1993/ Vol. 42/ No. RR-1
HTML  |  PDF
 
Update on Adult Immunization
Source: MMWR November 15, 1991 / Vol. 40 / No. RR-120
HTML  |  PDF
 
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
 
Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)
Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08
HTML  |  PDF
 
Haemophilus b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01
HTML  |  PDF
This page was reviewed on June 20, 2014
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.